Preview

Siberian journal of oncology

Advanced search

Changes in the content of hormones of hypothalamic-pituitary-thyroid axis in growth of single and multiple primary tumors in the presence of comorbidity

https://doi.org/10.21294/1814-4861-2022-21-5-82-89

Abstract

Introduction. Thyroid dysfunction is known to be associated with higher risks of cancer development. The purpose of this study was to analyze levels of thyroid axis hormones in the hypothalamus, pituitary gland, thyroid, and blood serum of male and female Balb/c nude mice with B16/F10 melanoma and/or lewis lung carcinoma. Material and methods. Male and female Balb/c nude mice were divided into groups: 1 – intact mice (n=7), 2 – mice with b16/f10 melanoma (n=7), 3 – mice with lewis lung carcinoma (LLC) (n=7), 4 – mice with melanoma and LLC (n=7). Levels of thyroid-stimulating hormone (TSH), triiodothyronine (fT3), and thyroxine (fT4) were measured by ria in homogenates of the hypothalamus, pituitary gland, thyroid and blood serum of all animals, and TH-releasing was measured by ELISA. Statistical processing of results was performed using the Statistica 10.0 program. Results. TH-releasing was reduced in the hypothalamus of all tumor-bearing mice, compared to initial values. TSH levels in the pituitary gland and thyroid were changed only in males with the combination of tumors (increased by 2.8 and 1.5 times, respectively). Levels of free forms of hormones in the thyroid in animals of both genders sharply increased, together with the elevation of TSH in the blood serum and, as a result, the decrease of fТ3 and fТ4 levels. Conclusion. Female and male Balb/c nude mice of the studied groups demonstrated hypothalamic dysfunction manifested by the absence of regulation in the hypothalamus-pituitary-thyroid relationship, and by the hypothyroid status of animals.

About the Authors

O. I. Kit
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

Oleg I. Kit, MD, Professor, Academician of the Russian Academy of Sciences, General Director

63, 14-th Liniya St., 344037, Rostov-on-Don, Russia



E. M. Frantsiyants
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

 Elena M. Frantsiyants, Professor, Deputy General Director for Science 

63, 14-th Liniya St., 344037, Rostov-on-Don, Russia



I. V. Kaplieva
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

 Irina V. Kaplieva, MD, DSc, Head of the Laboratory for the Study of the Pathogenesis of Malignant Tumors

63, 14-th Liniya St., 344037, Rostov-on-Don, Russia



V. A. Bandovkina
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

 Valeria A. Bandovkina, DSc, Senior Researcher, Laboratory for the Study of the Pathogenesis of Malignant Tumors 

63, 14-th Liniya St., 344037, Rostov-on-Don, Russia



A. I. Shikhlyarova
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

 Alla I. Shikhlyarova, Professor, Senior Researcher, Laboratory for the Study of the Pathogenesis of Malignant Tumors 

63, 14-th Liniya St., 344037, Rostov-on-Don, Russia



I. A. Goroshinskaya
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

Irina A. Goroshinskaya, Professor, Senior Researcher, Laboratory for the Study of the Pathogenesis of Malignant Tumors 

63, 14-th Liniya St., 344037, Rostov-on-Don, Russia



N. D. Cheryarina
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

 Natalya D. Cheryarina, Laboratory assistant, Laboratory for Studying the Pathogenesis of Malignant Tumors 

63, 14-th Liniya St., 344037, Rostov-on-Don, Russia



I. V. Neskubina
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

 Irina V. Neskubina, PhD, Senior Researcher, Laboratory for the Study of the Pathogenesis of Malignant Tumors 

63, 14-th Liniya St., 344037, Rostov-on-Don, Russia



Yu. A. Pogorelova
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

 Yulia A. Pogorelova, PhD, Senior Researcher, Laboratory for the Study of the Pathogenesis of Malignant Tumors 

63, 14-th Liniya St., 344037, Rostov-on-Don, Russia



E. I. Surikova
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

Ekaterina I. Surikova, PhD, Senior Researcher, Laboratory for the Study of the Pathogenesis of Malignant Tumors 

63, 14-th Liniya St., 344037, Rostov-on-Don, Russia



L. K. Trepitaki
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

 Lidia K. Trepitaki, PhD, Junior Researcher, Laboratory for the Study of the Pathogenesis of Malignant Tumors 

63, 14-th Liniya St., 344037, Rostov-on-Don, Russia



I. M. Kotieva
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

 Inga M. Kotieva, DSc, Researcher, Laboratory for the Study of the Pathogenesis of Malignant Tumors 

63, 14-th Liniya St., 344037, Rostov-on-Don, Russia



K. A. Shumarin
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

 Konstantin A. Shumarin, Postgraduate 

63, 14-th Liniya St., 344037, Rostov-on-Don, Russia



References

1. Gauthier B.R., Sola-García A., Cáliz-Molina M.Á., Lorenzo P.I., Cobo-Vuilleumier N., Capilla-González V., Martin-Montalvo A. Thyroid hormones in diabetes, cancer, and aging. Aging Cell. 2020; 19(11). doi: 10.1111/acel.13260.

2. Liu Y.C., Yeh C.T., Lin K.H. Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis. Int J Mol Sci. 2019; 20(20): 4986. doi: 10.3390/ijms20204986.

3. Kim E.Y., Chang Y., Lee K.H., Yun J.S., Park Y.L., Park C.H., Ahn J., Shin H., Ryu S. Serum concentration of thyroid hormones in abnormal and euthyroid ranges and breast cancer risk: A cohort study. Int J Cancer. 2019; 145(12): 3257–66. doi: 10.1002/ijc.32283.

4. Tran T.V., Kitahara C.M., de Vathaire F., Boutron-Ruault M.C., Journy N. Thyroid dysfunction and cancer incidence: a systematic review and meta-analysis. Endocr Relat Cancer. 2020; 27(4): 245–59. doi: 10.1530/ERC-19-0417.

5. Tseng F.Y., Lin W.Y., Li C.I., Li T.C., Lin C.C., Huang K.C. Subclinical hypothyroidism is associated with increased risk for cancer mortality in adult Taiwanese-a 10 years population-based cohort. PLoS One. 2015; 10(4). doi: 10.1371/journal.pone.0122955.

6. Pinter M., Haupt L., Hucke F., Bota S., Bucsics T., Trauner M., Peck-Radosavljevic M., Sieghart W. The impact of thyroid hormones on patients with hepatocellular carcinoma. PLoS One. 2017; 12(8). doi: 10.1371/journal.pone.0181878.

7. López-Noriega L., Capilla-González V., Cobo-Vuilleumier N., Martin-Vazquez E., Lorenzo P.I., Martinez-Force E., Soriano-Navarro M., García-Fernández M., Romero-Zerbo S.Y., Bermúdez-Silva F.J., DíazContreras I., Sánchez-Cuesta A., Santos-Ocaña C., Hmadcha A., Soria B., Martín F., Gauthier B.R., Martin-Montalvo A. Inadequate control of thyroid hormones sensitizes to hepatocarcinogenesis and unhealthy aging. Aging (Albany NY). 2019; 11(18): 7746–79. doi: 10.18632/aging.102285.

8. Franciyanc E.M., Neskubina I.V., Cheryarina N.D., Surikova E.I., Shihlyarova A.I., Bandovkina V.A., Nemashkalova L.A., Kaplieva I.V., Trepitaki L.K., Kachesova P.S., Kotieva I.M., Morozova M.I., Pogorelova YU.A. Functional state of mitochondria of cardiomyocytes in the malignant process against the background of comorbital pathology in the experiment. YUzhno-Rossijskij Okologicheskij Zhurnal. 2021; 2(3): 13–22. (in Russian). doi: 10.37748/2686-9039-2021-2-3-2.

9. Kit O.I., Kotieva I.M., Franciyanc E.M., Kaplieva I.V., Trepitaki L.K., Bandovkina V.A., Neskubina I.V., Surikova E.I., Cheryarina N.D., Pogorelova YU.A., Nemashkalova L.A. The effect of chronic neuropathic pain on the course of malignant melanoma b16/f10 in male mice. Izvestiya vysshih uchebnyh zavedenij. Severo-Kavkazskij region. Seriya: Estestvennye nauki. 2019; 1(201): 106–11. (in Russian).

10. Rigas A., Farmakis D., Papingiotis G., Bakosis G., Parissis J. Hypothalamic dysfunction in heart failure: pathogenetic mechanisms and therapeutic implications. Heart Fail Rev. 2018; 23(1): 55–61. doi: 10.1007/s10741-017-9659-7.

11. Yen C.C., Huang Y.H., Liao C.Y., Liao C.J., Cheng W.L., Chen W.J., Lin K.H. Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta. J Mol Endocrinol. 2006; 36(1): 9–21. doi: 10.1677/jme.1.01911.

12. Sinha R.A., Singh B.K., Yen P.M. Direct effects of thyroid hormones on hepatic lipid metabolism. Nat Rev Endocrinol. 2018; 14(5): 259–69. doi: 10.1038/nrendo.2018.10.

13. Frau C., Loi R., Petrelli A., Perra A., Menegon S., Kowalik MA., Pinna S., Leoni VP., Fornari F., Gramantieri L., Ledda-Columbano GM., Giordano S., Columbano A. Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats. Hepatology. 2015; 61(1): 249–59. doi: 10.1002/hep.27399.

14. Mancini A., Di Segni C., Raimondo S., Olivieri G., Silvestrini A., Meucci E., Currò D. Thyroid Hormones, Oxidative Stress, and Inflammation. Mediators Inflamm. 2016; 8. doi: 10.1155/2016/6757154.

15. Zambrano A., García-Carpizo V., Gallardo M.E., Villamuera R., Gómez-Ferrería M.A., Pascual A., Buisine N., Sachs L.M., Garesse R., Aranda A. The thyroid hormone receptor β induces DNA damage and premature senescence. J Cell Biol. 2014; 204(1): 129–46. doi: 10.1083/jcb.201305084.

16. Martínez-Iglesias O., García-Silva S., Regadera J., Aranda A. Hypothyroidism enhances tumor invasiveness and metastasis development. PLoS One. 2009; 4(7). doi: 10.1371/journal.pone.0006428.


Review

For citations:


Kit O.I., Frantsiyants E.M., Kaplieva I.V., Bandovkina V.A., Shikhlyarova A.I., Goroshinskaya I.A., Cheryarina N.D., Neskubina I.V., Pogorelova Yu.A., Surikova E.I., Trepitaki L.K., Kotieva I.M., Shumarin K.A. Changes in the content of hormones of hypothalamic-pituitary-thyroid axis in growth of single and multiple primary tumors in the presence of comorbidity. Siberian journal of oncology. 2022;21(5):82-89. (In Russ.) https://doi.org/10.21294/1814-4861-2022-21-5-82-89

Views: 484


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)